RMD
$231.69
Resmed
($1.10)
(.47%)
RMD
Earnings Whisper ®
N/A
3rd Quarter March 2025
Consensus:  $2.37
Revenue:  $1.28 Bil
Thursday
May 1
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when RMD reports earnings?
Beat
Meet
Miss

Where is RMD's stock price going from here?
Up
Flat
Down
Stock chart of RMD
Analysts
Summary of analysts' recommendations for RMD
Score
Grade
Pivots
Resistance
$236.31
$234.84
$233.27

$231.80

Support
$230.23
$228.76
$227.19
Tweet
Growth
Description
ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment.
Peers
Boston ScientificStrykerAbbottWatersBecton, Dickinson3MBaxter InternationalTeleflexIntegra LifeSciences HoldingsMerit Medical Systems